Patient-level and system-level barriers associated with treatment delays for ST elevation myocardial infarction in China.

Barriers associated with delay in STEMI treatment were identified at both patient and system levels. The results of this study provide a useful evidence base for future intervention development to improve the quality of STEMI treatment and patient outcomes in China and other countries in a similar situation.